Search

Tennisvedette Serena Williams (44) maakt haar rentree in het dubbelspel op het grastoernooi van Queen’s, bijna vier jaar na haar laatste wedstrijd, en heeft hiervoor gewicht verloren met het afslankmedicijn GLP-1, waarvan ze openlijk gebruik maakt in haar promotiecampagne. #SerenaWilliams #Tennis #GLP1

Une étude menée par une professeure adjointe de l'université du Colorado révèle que les médicaments comme l'Ozempic, utilisés pour traiter des troubles hormonaux, entraînent des changements inattendus dans le cerveau, notamment une augmentation des connexions dans le réseau saillance, soulevant ainsi des interrogations sur leurs effets à long terme sur la cognition et la personnalité. #Ozempic #GLP1 #santé

Los fármacos antiobesidad como el GLP-1, Ozempic, Wegovy y el recientemente investigado retatrutide, no solo ayudan en la pérdida de peso, sino que también aportan beneficios significativos en el corazón, riñones y hígado, actuando en múltiples sistemas del cuerpo gracias a su larga duración en el organismo y su capacidad de estimular la liberación de insulina. #GLP1 #Obesidad #FármacosAntiadiposos

V Anglii bude zaveden systém pokutování pro uživatele léků GLP-1, jako je Ozempic, protože jejich vedlejší účinky, jako je závratě a poruchy zraku, mohou ohrozit schopnost bezpečně řídit, což vyžaduje oznámení zdravotního stavu příslušným úřadům. #GLP1 #Ozempic #безопасностьнадороге

GLP-1 weight loss injections, which have revolutionized obesity treatment with around 100 million users worldwide, are facing challenges in accessibility on the NHS due to strict eligibility criteria and high costs, despite their efficacy highlighted by clinical trials showing substantial weight loss in patients. #WeightLoss #ObesityCrisis #GLP1 #GB #US #DK

Najnowsze badanie opublikowane w JAMA Network Open sugeruje, że leki GLP-1 mogą poprawić przeżywalność i zmniejszyć ryzyko nawrotu choroby u kobiet po raku piersi, szczególnie tych z otyłością lub cukrzycą typu 2, choć potrzebne są dalsze badania w celu wyjaśnienia mechanizmów ich działania. #zdrowie #rakpiersi #GLP1

Η ραγδαία εξάπλωση των φαρμάκων GLP-1 για απώλεια βάρους οδηγεί σε αλλαγές στις διατροφικές συνήθειες εκατομμυρίων Αμερικανών, οι οποίοι τρώνε λιγότερο και επιλέγουν πιο υγιεινές επιλογές, με αποτέλεσμα να επηρεάζεται αρνητικά η βιομηχανία εστίασης. #GLP1 #διατροφικέςσυνήθειες #απώλειαβάρους

Az Ozempic, a cukorbetegeknek szánt gyógyszer, amely fogyókúrás csodaszerként is népszerűvé vált, váratlanul megnövelte egy rágógumimárka, az Ice Breakers eladásait, mivel a gyógyszer használata kellemetlen szájszagot okoz, így nőtt a kereslet a mentolos termékek iránt. #Ozempic #GLP1 #szájhigiénia

Are we about to see a dangerous drop in birth rates in the most developed economies? At this rate, well over 1/4 of the US population will end up on a GLP-1 agonist, and young healthy adults get on them earlier and earlier. People report a blunting of desire across the board on #BirthRates #PublicHealth #GLP1Agonists #US

In a discussion on "The Ezra Klein Show," health journalist Julia Belluz explores the complex interplay between the scientific mechanisms and cultural factors behind the popularity of GLP-1 medications, which effectively induce weight loss by making the brain perceive a state similar to food poisoning. #GLP1 #Healthcare #DrugScience #Nocountrycodespresent.

Abnehmspritzen, insbesondere GLP-1-Medikamente, führen zu einem starken Anstieg der Nachfrage po Whey-Proteinen in der Lebensmittelindustrie, wodurch die Preise rapide steigen, Kapazitätsengpässe entstehen und Unternehmen massive Investitionen tätigen müssen, um der veränderten Verbraucheranforderung gerecht zu werden. #WheyProtein #GLP1 #FoodIndustry

L'attività motoria è fondamentale per potenziare l'efficacia dei nuovi farmaci anti-obesità, come gli analoghi di Glp-1, poiché aiuta a preservare la massa muscolare e a ridurre il rischio di recupero del peso perso dopo la sospensione della terapia, e i medici dovrebbero prestare maggiore attenzione a integrare l'esercizio fisico nei programmi di trattamento per l'obesità. #ObesityTreatment #ExerciseBenefits #GLP1Analogues

In her article, Julia Belluz examines the rising use of GLP-1 weight loss drugs in children with obesity and the ethical concerns surrounding their long-term effects, arguing that while these medications may provide immediate health benefits, they highlight a deeper societal failure to address the unhealthy food environment that contributes to childhood obesity. #ChildhoodObesity #HealthAndNutrition #GLP1 #US #CA #LA

GLP-1 medications like Ozempic and Wegovy are reshaping patient health and public discourse, as a study reveals that their increasing normalization reinforces dominant frameworks of weight stigma and individual responsibility, reflecting a structurally fatphobic narrative in Spain, which lacks acceptance of weight diversity and promotes a dichotomy between "good" and "bad" users based on perceived effort and morality. #GLP1 #WeightManagement #HealthDebate #ES